• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchOragenics
    Picture of Oragenics logo

    OGEN — Oragenics News Story

    $0.420.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    • Market Cap
      $1.88m
    • Enterprise Value
      -$1.98m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • OGEN Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    OGEN Dividends
    All News

    AMEX HALT EQUIPMENT CHANGEOVER LAST 0.49110

    Picture of Oragenics logoOragenics
    02/11/2020 17:37
    AMEX HALT  OGEN.A  EQUIPMENT CHANGEOVER LAST 0.49110
    

    Recent news on Oragenics

    See all news
    • Brief: Oragenics Reports Continued Clinical Progress, Provides Regulatory And NYSE American Listing Update

      28/08/2026 21:33
    • Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation

      07/05/2026 13:33
    • Brief: Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing

      07/05/2026 13:19
    • Brief: Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.

      05/05/2026 13:38
    • Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing

      21/10/2025 12:55

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.